Dicerna

Dicerna Pharmaceuticals

This biopharmaceutical company develops ribonucleic acid interference therapeutics to treat rare, chronic, and infectious diseases for healthcare providers and global pharmaceutical partners.

Airna

This company develops RNA editing therapeutics to treat patients with rare genetic and common cardiometabolic diseases.

DTX Pharma

This biotechnology firm develops RNA-based therapeutics for patients with rare neuromuscular and central nervous system disorders using a proprietary fatty acid delivery platform.

Argonaute RNA

This biotechnology firm develops bispecific siRNA therapeutics for cardiometabolic diseases, serving pharmaceutical partners and research institutions engaged in advanced therapeutic research.

Averna Therapeutics

This biotechnology company develops genomic medicines using RNA-based technology to insert therapeutic genes into safe genomic locations for patients with various diseases.

Novarna

This company develops an artificial intelligence platform to design and validate RNA therapeutics for biopharmaceutical partners.

Kerna

This company develops an artificial intelligence platform to design and deliver messenger ribonucleic acid medicines for patients with previously untreatable conditions.

City Therapeutics

This biotechnology company develops next-generation RNA interference therapeutics for patients with thromboembolic diseases, retinal disorders, and anaemia.